AbbVie Inc. recalls Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Onl
Recalled March 8, 2017 · FDA recall D-0495-2017 · AbbVie
Hazard
Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life · FDA Class II
Units
4021 cartons, 7 100-mL cassettes each
Sold at
TN and IL
Description
Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life
Product
Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07
Manufacturer(s)
AbbVie Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →